Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Mar-24 5:32 PM View:  | Xeris Biopharma Holdings, I... (XERS) | 18-Mar-24 | Option Exercise | 215,600 | $1.99 | $429,044.00 | 40% 535.81K to 751.41K | |
| 01-Apr-24 5:43 PM View: | Xeris Biopharma Holdings, I... (XERS) | 15-Mar-24 | Acquisition (other) | 89,571 | -- | -- | 12% 751.41K to 840.98K | |
| 07-Jun-23 4:59 PM View: | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 9% 493.31K to 535.81K | |
| 05-Jun-23 6:53 PM View: | LecTec Corp. (AXGN) | 01-Jun-23 | Option Exercise | 6,459 | -- | -- | 100% 0 to 6.46K | |
| 09-Jun-22 5:13 PM View: | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 3% 478.31K to 493.31K | |
| 06-Oct-21 7:42 PM View: | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 610,092 | -- | -- | (100%) 610.09K to 0 | |
| 05-Oct-21 7:52 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Oct-21 | Grant | 478,312 | -- | -- | 100% 0 to 478.31K | |
| 05-Oct-21 7:24 PM View: | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 334,868 | $2.06 | $689,828.00 | (35%) 944.96K to 610.09K | 4% |
| 07-Jul-21 5:01 PM View: | Strongbridge Biopharma Plc (SBBP) | 02-Jul-21 | Payment of Exercise | 50,867 | $3.08 | $156,670.00 | (5%) 995.83K to 944.96K | 36% |
| 09-Apr-21 5:13 PM View: | Strongbridge Biopharma Plc (SBBP) | 08-Apr-21 | Payment of Exercise | 17,325 | $2.68 | $46,431.00 | (2%) 1.01M to 995.83K | 26% |
| 08-Jan-21 8:33 AM View: | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 491,000 | -- | -- | 94% 522.15K to 1.01M | |
| 07-Jul-20 8:11 AM View: | Strongbridge Biopharma Plc (SBBP) | 02-Jul-20 | Grant | 315,000 | -- | -- | 152% 207.15K to 522.15K | |
| 02-Jul-20 4:29 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 15-Jun-20 6:59 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 18-May-20 4:51 PM View: | Strongbridge Biopharma Plc (SBBP) | 15-May-20 | Payment of Exercise | 15,348 | $2.86 | $43,895.30 | (7%) 222.5K to 207.15K | 31% |
| 10-Apr-20 8:07 AM View: | Strongbridge Biopharma Plc (SBBP) | 08-Apr-20 | Grant | 182,500 | -- | -- | 456% 40.0K to 222.5K | |
| 02-Jul-19 9:09 PM View: | Cempra, Inc. (MLNT) | 27-Jun-19 | Private Sale | 13,000 | $5.57 | $72,441.20 | (26%) 50.4K to 37.4K | |
| 17-Jun-19 5:26 PM View: | Portola Pharmaceuticals Inc (PTLA) | 13-Jun-19 | Grant | 4,194 | -- | -- | 47% 9.0K to 13.19K | |
| 26-Jun-19 4:06 PM View: | Cempra, Inc. (MLNT) | 22-May-19 | Option Exercise | 50,000 | -- | -- | 12500% 0.4K to 50.4K | |
| 16-May-19 4:12 PM View: | Strongbridge Biopharma Plc (SBBP) | 15-May-19 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 08-Jun-18 6:14 PM View: | Portola Pharmaceuticals Inc (PTLA) | 08-Jun-18 | Grant | 3,000 | -- | -- | 50% 6.0K to 9.0K | |
| 13-Feb-18 4:52 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,130 | $18.00 | $92,340.00 | (100%) 5.13K to 0 | |
| 19-Jun-17 6:07 PM View: | Portola Pharmaceuticals Inc (PTLA) | 16-Jun-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 05-Jun-17 9:55 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 20-Jun-16 3:39 PM View: | Portola Pharmaceuticals Inc (PTLA) | 17-Jun-16 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 06-Jun-16 6:02 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 02-Jun-16 | Grant | 9,800 | -- | -- | 100% 0 to 9.8K | |
| 08-Jul-14 2:39 PM View: | Dendreon Corp. (DNDN) | 03-Jul-14 | Payment of Exercise | 12,090 | $2.29 | $27,686.10 | (1%) 1.08M to 1.07M | 95% |
| 28-May-14 5:23 PM View: | Cempra, Inc. (MLNT) | 23-May-14 | Market Purchase | 10,000 | $9.10 | $90,980.00 | 100% 0 to 10.0K | (97%) |
| 04-Apr-14 6:12 PM View: | Dendreon Corp. (DNDN) | 03-Apr-14 | Payment of Exercise | 9,459 | $2.93 | $27,714.90 | (< 1%) 1.09M to 1.08M | 96% |
| 12-Feb-14 2:38 PM View: | Dendreon Corp. (DNDN) | 10-Feb-14 | Grant | 66,501 | -- | -- | 6% 1.05M to 1.12M | |
| 12-Feb-14 2:38 PM View: | Dendreon Corp. (DNDN) | 10-Feb-14 | Payment of Exercise | 22,843 | $2.81 | $64,188.80 | (2%) 1.12M to 1.09M | 96% |
| 07-Jan-14 3:41 PM View: | Dendreon Corp. (DNDN) | 03-Jan-14 | Grant | 395,189 | -- | -- | 57% 689.62K to 1.08M | |
| 07-Jan-14 3:41 PM View: | Dendreon Corp. (DNDN) | 03-Jan-14 | Payment of Exercise | 35,796 | $3.08 | $110,252.00 | (3%) 1.08M to 1.05M | 96% |
| 03-Jan-14 7:14 PM View: | Dendreon Corp. (DNDN) | 31-Dec-13 | Payment of Exercise | 38,382 | $2.99 | $114,762.00 | (5%) 728.0K to 689.62K | 96% |
| 07-Jan-13 5:12 PM View: | Dendreon Corp. (DNDN) | 03-Jan-13 | Grant | 395,189 | -- | -- | 119% 332.82K to 728.0K | |
| 02-Jan-13 3:07 PM View: | Dendreon Corp. (DNDN) | 31-Dec-12 | Payment of Exercise | 40,342 | $5.29 | $213,409.00 | (11%) 373.16K to 332.82K | 98% |
| 02-Feb-12 4:01 PM View: | Dendreon Corp. (DNDN) | 31-Jan-12 | Grant | 349,780 | -- | -- | 922% 37.94K to 387.72K | |
| 04-Jan-12 4:17 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 03-Jan-12 | Market Sale (Planned) | 17,650 | $2.30 | $40,595.00 | (7%) 270.0K to 252.35K | 75% |
| 05-Jan-12 6:42 PM View: | Dendreon Corp. (DNDN) | 03-Jan-12 | Grant | 25,000 | -- | -- | 193% 12.94K to 37.94K | |
| 22-Nov-11 6:40 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 21-Nov-11 | Market Purchase | 5,000 | $2.30 | $11,500.00 | 2% 265.0K to 270.0K | (75%) |
| 21-Nov-11 12:06 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 18-Nov-11 | Market Purchase | 1,000 | $2.36 | $2,359.80 | < 1% 258.0K to 259.0K | (76%) |
| 21-Nov-11 12:06 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 18-Nov-11 | Market Purchase | 10,000 | $2.28 | $22,800.00 | 4% 259.0K to 269.0K | (75%) |
| 07-Nov-11 5:50 PM View: | Dendreon Corp. (DNDN) | 04-Nov-11 | Market Purchase | 2,500 | $6.68 | $16,689.00 | 24% 10.44K to 12.94K | (98%) |
| 16-Sep-11 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-11 | Market Purchase | 25,000 | $4.10 | $102,492.00 | 11% 231.5K to 256.5K | (86%) |
| 16-Sep-11 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-11 | Market Purchase | 1,500 | $4.09 | $6,135.00 | < 1% 256.5K to 258.0K | (86%) |
| 16-Sep-11 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Sep-11 | Market Purchase | 1,500 | $3.88 | $5,823.75 | < 1% 230.0K to 231.5K | (85%) |
| 30-Aug-11 7:48 PM View: | Dendreon Corp. (DNDN) | 18-Aug-11 | Grant | 10,443 | -- | -- | 100% 0 to 10.44K | |
| 02-Feb-11 4:59 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Jan-11 | Grant | 230,000 | $9.23 | $2,122,900.00 | 100% 0 to 230.0K | (94%) |
| 02-Feb-11 4:59 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Jan-11 | Grant Duplicate | 230,000 | $9.23 | $2,122,900.00 | 100% 0 to 230.0K | (94%) |
| 24-Nov-08 4:25 PM View: | Imclone Systems Inc. (IMCL) | 21-Nov-08 | Disposition (change in control) | 18,708 | $70.00 | $1,309,560.00 | (100%) 18.71K to 0 | < 1% |